NINGBO INNO PHARMCHEM CO.,LTD. specializes in the provision of advanced chemical compounds, with Gefitinib CAS 184475-35-2 being a prominent example within our pharmaceutical intermediates range. This compound, known chemically as N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine, is indispensable in the synthesis of targeted therapies, particularly for Non-Small Cell Lung Cancer (NSCLC). Our commitment to quality ensures that this vital pharmaceutical intermediate supports the efficacy of critical medical treatments.

The core value of Gefitinib lies in its function as a protein kinase inhibitor. It specifically targets and inhibits the activity of tyrosine kinases, such as EGFR, which are often overactive in certain types of cancer. By blocking these signaling pathways, Gefitinib effectively slows or stops the growth of cancer cells. This precision in targeting makes it a cornerstone of modern cancer treatment strategies, offering a more refined approach compared to conventional therapies.

For pharmaceutical manufacturers and researchers, sourcing a reliable Gefitinib pharmaceutical intermediate is paramount. The compound's molecular formula is C22H24ClFN4O3, with a molecular weight of 446.902. It typically presents as a white to beige powder, with a melting point of 119-120°C. The integrity of these characteristics is vital for successful drug synthesis. NINGBO INNO PHARMCHEM CO.,LTD. rigorously tests its Gefitinib intermediate to ensure it meets stringent purity and quality specifications, thereby facilitating consistent and effective therapeutic outcomes.

The application of Gefitinib extends to critical research in medical chemistry and drug development. Its well-defined mechanism of action as a kinase inhibitor makes it a valuable tool for studying cellular signaling pathways involved in cancer. Furthermore, understanding potential side effects, such as transient elevations in liver enzymes, is crucial for both drug developers and clinicians. This knowledge underscores the importance of adhering to strict manufacturing protocols and patient monitoring guidelines when using Gefitinib-based treatments.

In summary, Gefitinib CAS 184475-35-2 is more than just a chemical compound; it is an enabler of advanced medical treatments. NINGBO INNO PHARMCHEM CO.,LTD. is proud to supply this essential pharmaceutical intermediate, supporting the global effort to combat diseases like NSCLC. Our focus on delivering high-quality materials, coupled with our expertise in chemical synthesis, positions us as a trusted partner for the pharmaceutical industry. We are dedicated to furthering therapeutic innovation through the reliable provision of compounds like Gefitinib.